BioCentury | Aug 15, 2018
Emerging Company Profile

Breaking bad biofilms

...for undisclosed terms. These include SNSP114 in Phase I testing for bronchiectasis, and preclinical compounds SNSP115...
BioCentury | Jun 29, 2017
Financial News

Pulmonary newco Synspira raises $8M in its pipeline: SNSP115 for pneumonia and SNSP146 for chronic obstructive pulmonary disease (COPD). Chris Lieu SNSP113 SNSP115 SNSP146 Synspira...
Items per page:
1 - 2 of 2